Autoimmune hepatitis and pregnancy: considerations for the clinician

References

• Galaski J, Weiler-Normann C, Schakat M, et al. Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing. J Hepatol. 2021 Feb;74:312–320.
   PubMed Web of Science ®Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008 Jul;48:169–176.
   PubMed Web of Science ®Google Scholar
• Zachou K, Weiler‐Normann C, Muratori L, et al. Permanent immunosuppression in SLA/LP‐positive autoimmune hepatitis is required although overall response and survival are similar. Liver Int. 2020 Feb;40:368–376.
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Autoimmune hepatitis. Part B: diagnosis. Expert Rev Gastroenterol Hepatol. 2007 Oct;1:129–143.
   PubMedGoogle Scholar
• Heneghan MA, Yeoman AD, Verma S, et al. Autoimmune hepatitis. Lancet. 2013;382:1433–1444.
   PubMed Web of Science ®Google Scholar
• Grønbæk L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014 Mar;60:612–617.
   PubMed Web of Science ®Google Scholar
• Lohse A, Chazouilleres O, Dalekos G, et al EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol.Oct 2015;63:971–1004.
   PubMed Web of Science ®Google Scholar
• Westbrook RH, Yeoman AD, Kriese S, et al. Outcomes of pregnancy in women with autoimmune hepatitis. J Autoimmun. 2012 May;38:J239–J244.
   PubMed Web of Science ®Google Scholar
• Heneghan MA. Management and outcome of pregnancy in autoimmune hepatitis. Gut. 2001 Jan;48:97–102.
   PubMed Web of Science ®Google Scholar
• Grønbaek L, Vilstrup H, Jepsen P. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Aliment Pharmacol Ther. 2018 Sep;48:655–663.
   PubMed Web of Science ®Google Scholar
• Buchel E, Steenbergen W, Nevens F, et al. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol. 2002 Dec;97:3160–3165.
   PubMed Web of Science ®Google Scholar
• Terrabuio DRB, Abrantes-Lemos CP, Carrilho FJ, et al. Follow-up of pregnant women with autoimmune hepatitis. J Clin Gastroenterol. 2009 Apr; 43:350–356.
   PubMed Web of Science ®Google Scholar
• Schramm C, Herkel J, Beuers U, et al. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006 Mar;101:556–560.
   PubMed Web of Science ®Google Scholar
• Sajja S, Idler J, Saad J, et al. Acute liver failure in pregnancy due to autoimmune hepatitis. BMJ Case Rep. 2021 Aug;14:e241355.
   PubMedGoogle Scholar
• Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in embryo implantation and the immune response to pregnancy. J Clin Invest. 2018 Oct;128:4224–4235.
   PubMed Web of Science ®Google Scholar
• Bozward AG, Wootton GE, Podstawka O, et al. Autoimmune hepatitis: tolerogenic immunological state during pregnancy and immune escape in post-partum. Front Immunol. 2020 Sep;11. https://doi.org/10.3389/fimmu.2020.591380.
   Google Scholar
• Xiong H, Zhou C, Qi G. Proportional changes of CD4+CD25+Foxp3+ regulatory T cells in maternal peripheral blood during pregnancy and labor at term and preterm. Clin Investig Med. 2010 Dec;33:422.
   Web of Science ®Google Scholar
• Danielsson Borssén Å, Wallerstedt S, Nyhlin N, et al. Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis. Scand J Gastroenterol. 2016 Apr;51:479–485.
   PubMed Web of Science ®Google Scholar
• Werner M, Björnsson E, Prytz H, et al. Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? Scand J Gastroenterol. 2007 Jan;42:986–991.
   PubMed Web of Science ®Google Scholar
• Nomuras RMY, Kleine RT, Igai AMK, et al. Clinical and obstetrical management of pregnant women with autoimmune hepatitis complicated by moderate or severe thrombocytopenia. Rev Assoc Med Bras. 59:28–34. [Online]. Available. http://www.ncbi.nlm.nih.gov/pubmed/23440139
   PubMed Web of Science ®Google Scholar
• Gleeson D, Heneghan MA. British society of gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011 Dec;60:1611–1629.
   PubMed Web of Science ®Google Scholar
• Westbrook RH, Yeoman AD, O’Grady JG, et al. Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol. 2011 Aug; 9:694–699. This may allow anticipation of potential complications so an appropriate surveillance strategy for the individual can be made
   PubMed Web of Science ®Google Scholar
• Gonsalkorala ES, Cannon MD, Lim TY, et al. Non-Invasive markers (ALBI and APRI) predict pregnancy outcomes in women with chronic liver disease. Am J Gastroenterol. 2019 Feb;114:267–275.
   PubMed Web of Science ®Google Scholar
• Shaheen AAM, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int. 2010 Feb;30(2):275–283.
   PubMed Web of Science ®Google Scholar
• Flemming JA, Mullin M, Lu J, et al. Outcomes of pregnant women with cirrhosis and their infants in a population-based study. Gastroenterology. 2020 Nov;159(5):1752–62.e10.
   PubMed Web of Science ®Google Scholar
• Sandhu BS, Sanyal AJ. Pregnancy and liver disease. Gastroenterology Clinics of North America. 2003 Mar;32(1):407–436.
   PubMed Web of Science ®Google Scholar
• Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016 Feb;111:176–194.
   PubMed Web of Science ®Google Scholar
• Mack CL, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases. Hepatology. 2020 Aug;72:671–722.
   PubMed Web of Science ®Google Scholar
• Savas N. Gastrointestinal endoscopy in pregnancy. World J Gastroenterol. 2014;20:15241.
   PubMed Web of Science ®Google Scholar
• Wang CW SM, Grab J, Tana MM. Outcomes of pregnancy in autoimmune hepatitis: a population-based study. Hepatology. 2021; This may allow specific management to be implemeneted such as aspirin prophylaxis for preeclampsia. https://doi.org/10.1002/hep.32132.
   Google Scholar
• Stokkeland K, et al. Increased risk of preterm birth in women with autoimmune hepatitis - a nationwide cohort study. Liver Int. 2016 Jan;36:76–83.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017 Aug;377:613–622.
   PubMed Web of Science ®Google Scholar
• LeFevre ML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive services task force recommendation statement. Ann Int Med. 2014 Dec;161:819.
   PubMed Web of Science ®Google Scholar
• Hypertension in pregnancy. Obstet Gynecol.Nov 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• [ Online]. https://www.nice.org.uk/guidance/ng133
   Google Scholar
• Aggarwal N, Chopra S, Suri V, et al. Pregnancy outcome in women with autoimmune hepatitis. Arch Gynecol Obstet. 2011 Jul;284:19–23.
   PubMed Web of Science ®Google Scholar
• Friedman DM, et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block. Circulation. 2008 Jan;117:485–493.
   PubMed Web of Science ®Google Scholar
• Wainwright B, et al. Autoimmune-mediated congenital heart block. Best Pract Res Clin Obstet Gynaecol. 2020 Apr;64:41–51.
   PubMed Web of Science ®Google Scholar
• Heriot JA, Steven CM, Sattin RS. Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesophageal varices. Br J Anaesth. 1996 Feb;76:325–327.
   PubMed Web of Science ®Google Scholar
• Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016 Apr;64:933–945.
   PubMed Web of Science ®Google Scholar
• Mistilis SP, Skyring AP, Blackburn CRB. NATURAL HISTORY OF ACTIVE CHRONIC HEPATITIS. Australas Ann Med. 1968 Aug;17:214–223.
   PubMedGoogle Scholar
• Manns MP, et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology. 2010 Oct;139:1198–1206.
   PubMed Web of Science ®Google Scholar
• Carmichael SL, Shaw GM, Ma C, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007 Dec;197:585.e1–585.e7.
   PubMed Web of Science ®Google Scholar
• Bay Bjørn A-M, Ehrenstein V, Hundborg HH, et al. Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring. Am J Ther. 2014;21:73–80.
   PubMed Web of Science ®Google Scholar
• Al Arfaj A, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010 Dec;19:1665–1673.
   PubMed Web of Science ®Google Scholar
• Pape S, et al. Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol. 2019 Sep;17:2068–2075.e2.
   PubMed Web of Science ®Google Scholar
• Rahim MN, Ran S, Shah S, et al. Safety and efficacy of budesonide during pregnancy in women with autoimmune hepatitis. Hepatology. 2020 Nov: hep.31634. DOI:https://doi.org/10.1002/hep.31634.
   Google Scholar
• Götestam Skorpen C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016 May;75:795–810.
   PubMed Web of Science ®Google Scholar
• Akbari M, Shah S, Velayos FS, et al. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jan;19:15–22.
   PubMed Web of Science ®Google Scholar
• Perez-Aytes A, et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet Part A. 2008 Jan; 146A:1–7.
   PubMed Web of Science ®Google Scholar
• Hoeltzenbein M, et al. Teratogenicity of mycophenolate confirmed in a prospective study of the European network of teratology information services. Am J Med Genet Part A. 2012 Mar; 158A:588–596.
   PubMed Web of Science ®Google Scholar
• Sifontis NM, Coscia LA, Constantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006 Dec;82:1698–1702.
   PubMed Web of Science ®Google Scholar
• Mahadevan U, et al. 865 PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterology. 2012 May;142:S–149.
   Web of Science ®Google Scholar
• Gerosa M, Argolini LM, Artusi C, et al. The use of biologics and small molecules in pregnant patients with rheumatic diseases. Expert Rev Clin Pharmacol. 2018 Oct;11:987–998.
   PubMed Web of Science ®Google Scholar
• Bar Oz B, Hackman R, Einarson T, et al. PREGNANCY OUTCOME AFTER CYCLOSPORINE THERAPY DURING PREGNANCY: a META-ANALYSIS1. Transplantation. 2001 Apr;71:1051–1055.
   PubMed Web of Science ®Google Scholar
• Zheng S, et al. Pharmacokinetics of Tacrolimus during pregnancy. Ther Drug Monit. 2012 Dec;34:660–670.
   PubMed Web of Science ®Google Scholar
• Sau A, Clarke S, Bass J, et al. Azathioprine and breastfeeding-is it safe? BJOG An Int J Obstet Gynaecol. 2007 Apr; 114:498–501.
   PubMed Web of Science ®Google Scholar
• Yuksel M, et al. A novel ‘humanized mouse’ model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology. 2015 Nov;62:1536–1550.
   PubMed Web of Science ®Google Scholar
• Seki E, et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med. 2007. https://doi.org/10.1038/nm1663.
   Google Scholar
• Lin R, Zhou L, and Zhang J, et al. Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int J Clin Exp Pathol. 2015;8(5): 5153–5160.
   PubMed Web of Science ®Google Scholar
• Migita K, et al. Elevated serum BAFF levels in patients with autoimmune hepatitis. Hum Immunol. 2007 Jul;68:586–591.
   PubMed Web of Science ®Google Scholar